Silencing Cyr61 in invasive breast cancer cells caused a major loss of MMP-1 induction from stromal fibroblasts and inhibited the tumorigenicity of breast cancer cells (Nguyen et al., 2006). This evidence concerns the gene CCN1 and breast carcinoma.